Sign in

CIK 0001719714

  • Non-accelerated filer
  • Smaller reporting company

Mereo BioPharma Group plc

Sign in to watch
Ticker
MREO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+44 3330237300
Business address
ONE CAVENDISH PLACE, FOURTH FLOOR, LONDON, United Kingdom, W1G 0QF
  1. 4 Open-market sale Chief Executive Officer sold 132,985 shares at an average $3.49 ($463,487)
  2. 4 Open-market sale Hughes-Wilson Alexandra sold 33,102 shares at an average $3.49 ($115,369)
  3. 4 Exercise or conversion Chief Scientific Officer acquired 69,000 shares (option exercise)
  4. 4 Exercise or conversion Chief Executive Officer acquired 282,090 shares (option exercise)
  5. 4 Exercise or conversion General Counsel acquired 98,400 shares (option exercise)
  6. 4 Exercise or conversion Chief Financial Officer acquired 90,000 shares (option exercise)
  7. 4 Exercise or conversion Hughes-Wilson Alexandra acquired 60,000 shares (option exercise)
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award Director acquired 25,050 shares (grant or award)
  10. 4 Grant or award Director acquired 12,550 shares (grant or award)
  11. 4/A Insider Changes in Ownership
  12. 4 Open-market sale Hughes-Wilson Alexandra sold 100,432 shares at an average $2.97 ($297,788)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 4 · 80 filings